<DOC>
	<DOCNO>NCT00148980</DOCNO>
	<brief_summary>Normal bone marrow function depend coexistence normal hematopoietic stem cell microenvironment mostly locate medullary part bone . Stem cell function properly absence adequate microenvironment . Whereas malignant non-malignant hematologic disease cause deficiency abnormal stem cell , stem cell transplantation treatment choice result cure , diseases MDS , myelofibrosis , condition associate abnormal microenvironment , pancytopenia may occur despite presence apparently normal hematopoietic cell recognizable cytogenetic abnormality . We , investigator Hadassah Medical Organization , prove experimental study entire osteohematopoietic complex consist trabecular bone , hematopoietic microenvironment ( stromal origin ) hematopoietic tissue successfully transfer directly ablate bone marrow cavity one-step transplantation procedure . The goal study enhance hematopoiesis patient myelofibrosis syndrome intraosseous inoculation demineralize bone matrix ( DBM ) together allogeneic bone marrow cell ( BMC ) .</brief_summary>
	<brief_title>Creation Bone Marrow Microenvironment Treatment Myelodysplastic Syndrome ( MDS ) Conjunction With Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<criteria>Patients impaired marrow stem cell cytogenetic analysis morphology ( blast ) , consider normal candidate allogeneic BMT . Such patient also entitle allogeneic bone marrow transplantation intraosseous DBM . Patients document myelofibrosis entitle allogeneic bone marrow transplantation intraosseous DBM . Patients anticipated life expectancy &lt; 4 week . Pregnant lactating woman . Patients unrelated disease relevant clinical problem may permit evaluation result study . Patients 18 year old .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Myelodysplastic syndrome ( MDS )</keyword>
	<keyword>Allogeneic stem cell transplantation</keyword>
	<keyword>Demineralized bone matrix ( DBM )</keyword>
	<keyword>Bone marrow microenvironment</keyword>
</DOC>